In the Phase 2 trial published in the New England Journal of Medicine (2023), retatrutide was administered as a once-weekly subcutaneous injection using a structured dose-escalation schedule
Gastrointestinal side effects (nausea, vomiting) may exacerbate dehydration and prerenal acute kidney injury in susceptible patients, requiring hydration counseling
Once that feels comfortable, you might boost your lunch with extra fiber
JAMA Cardiol (2018) 3:2807
Obesity and its impact on female reproductive health: unraveling the connections
Additionally, animal studies have found that exposure to glucagon-like peptide-1 receptor agonists in pregnancy resulted in adverse outcomes for offspring that included decreased fetal growth, skeletal and visceral anomalies, and embryonic death